Multiple sclerosis and symptom management
Research activity in multiple sclerosis centers on symptomatic care, with a strong focus on fatigue and functional improvement in people living with the disease.
- Fatigue assessment
- Amantadine
- Transcranial magnetic stimulation
- Combination symptomatic therapy
The sponsor also supports work on maintaining clinical benefit over time in multiple sclerosis, reflecting interest in sustained symptom control.
Neuroimmunology and inflammatory neurological disease
The trial portfolio includes treatment strategies for immune-mediated neurological disorders, with emphasis on therapies that address inflammation-related manifestations in multiple sclerosis.
- Symptomatic immunomodulatory treatment
- Disodium cromoglycate
- Clinical response durability
These studies place the sponsor within the field of neuroinflammation and patient-centered management of chronic neurological disease.
Non-infectious uveitis and ocular inflammation
Another area of interest is non-infectious uveitis, where the sponsor is involved in evaluating treatments for ocular inflammatory disease.
- Methotrexate
- Adalimumab
- Combination immunotherapy
- Blinded outcome assessment
This work reflects engagement with therapies used to control persistent inflammation affecting the eye.
